Literature DB >> 9155621

Ventricular tachycardia initiated by high energy cardioversion in a patient with an implantable cardioverter defibrillator.

M Chinushi1, Y Aizawa, K Higuchi.   

Abstract

A transvenous implantable cardioverter defibrillator (ICD) was implanted into a 58 year old woman with idiopathic dilated cardiomyopathy who had drug refractory monomorphic ventricular tachycardia (VT). Antitachycardia pacing failed to terminate the VT; termination was attempted at 24 J, which was above the defibrillation threshold. When cardioversion at 24 J was delivered, VT with a different morphology and slower rate was reproducibly initiated. At 3 J, however, the original VT was successfully terminated without initiation of the slower VT. A new VT may be induced by high energy cardioversion. This may be a manifestation of the proarrhythmic potential of ICDs.

Entities:  

Mesh:

Year:  1997        PMID: 9155621      PMCID: PMC484736          DOI: 10.1136/hrt.77.4.373

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  10 in total

1.  Aftereffects of high-intensity DC stimulation on the electromechanical performance of ventricular muscle.

Authors:  I Kodama; N Shibata; I Sakuma; K Mitsui; M Iida; R Suzuki; Y Fukui; S Hosoda; J Toyama
Journal:  Am J Physiol       Date:  1994-07

Review 2.  Implantable cardioverter defibrillator proarrhythmia: case report and review of the literature.

Authors:  T J Cohen; W W Chien; K G Lurie; M A Lee; M D Lesh; M M Scheinman; J C Griffin
Journal:  Pacing Clin Electrophysiol       Date:  1991-09       Impact factor: 1.976

3.  Demonstration of the mechanism of transient entrainment and interruption of ventricular tachycardia with rapid atrial pacing.

Authors:  A L Waldo; R W Henthorn; V J Plumb; W A MacLean
Journal:  J Am Coll Cardiol       Date:  1984-02       Impact factor: 24.094

4.  Long-term outcome with the automatic implantable cardioverter-defibrillator.

Authors:  R A Winkle; R H Mead; M A Ruder; V A Gaudiani; N A Smith; W S Buch; P Schmidt; T Shipman
Journal:  J Am Coll Cardiol       Date:  1989-05       Impact factor: 24.094

5.  Frequency of presumed reentry with an excitable gap in sustained ventricular tachycardia unassociated with coronary artery disease.

Authors:  Y Aizawa; N Naitoh; H Kitazawa; Y Kusano; H Uchiyama; T Washizuka; A Shibata
Journal:  Am J Cardiol       Date:  1993-10-15       Impact factor: 2.778

6.  Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest.

Authors:  A C Powell; T Fuchs; D M Finkelstein; H Garan; D S Cannom; B A McGovern; E Kelly; G J Vlahakes; D F Torchiana; J N Ruskin
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

7.  Ventricular fibrillation induced by low-energy shocks from programmable implantable cardioverter-defibrillators in patients with coronary artery disease.

Authors:  M R Lauer; C Young; L B Liem; L Ottoboni; J Peterson; P Goold; R J Sung
Journal:  Am J Cardiol       Date:  1994-03-15       Impact factor: 2.778

8.  The cellular electrophysiologic changes induced by high-energy electrical ablation in canine myocardium.

Authors:  J H Levine; J F Spear; H F Weisman; A H Kadish; C Prood; C O Siu; E N Moore
Journal:  Circulation       Date:  1986-04       Impact factor: 29.690

9.  Incidence and mechanism of interruption of reentrant ventricular tachycardia with rapid ventricular pacing.

Authors:  Y Aizawa; S Niwano; M Chinushi; M Tamura; Y Kusano; T Miyajima; H Kitazawa; A Shibata
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

Review 10.  The proarrhythmic potential of implantable cardioverter-defibrillators.

Authors:  S L Pinski; G J Fahy
Journal:  Circulation       Date:  1995-09-15       Impact factor: 29.690

  10 in total
  1 in total

Review 1.  Ventricular fibrillation induced by high-output ICD shock: report of cases and review of literature.

Authors:  Adil Sattar; Shmuel Inbar
Journal:  BMJ Case Rep       Date:  2017-07-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.